Episode Details

Back to Episodes

What does FDA’s approval of generic liraglutide mean for obesity care?

Episode 546 Published 11 months, 2 weeks ago
Description
The FDA has approved a generic version of liraglutide injection, expanding access to obesity treatment by lowering costs and broadening eligibility across adults and adolescents, though safety monitoring remains essential. A JAMA Network Open study found that overweight older adults had lower 30-day mortality after elective surgery compared to those of normal weight, highlighting the “obesity paradox” in surgical risk assessment. Finally, a new rapid, culture-free diagnostic method for sepsis can identify pathogens within two hours using microfluidics and deep learning, offering significant potential to improve survival in critically ill patients.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us